Page 82 - Read Online

Lonardo. Metab Target Organ Damage 2024;4:7 https://dx.doi.org/10.20517/mtod.2023.56 Page 7 of 7

17. Allen AM, Hicks SB, Mara KC, Larson JJ, Therneau TM. The risk of incident extrahepatic cancers is higher in non-alcoholic fatty
liver disease than obesity - a longitudinal cohort study. J Hepatol 2019;71:1229-36. DOI PubMed PMC
18. Lonardo A, Roncucci L. The "obese liver" and gastrointestinal cancer risk. Transl Gastroenterol Hepatol 2020;5:44. DOI PubMed
PMC
19. Lonardo A, Suzuki A. Concise review: breastfeeding, lactation, and NAFLD. An updated view of cross-generational disease
transmission and prevention. Metab Target Organ Damage 2023;3:16. DOI
20. Lin X, Chen C, Jiang T, et al. Metabolic dysfunction-associated fatty liver disease (MAFLD) is associated with cervical stromal
involvement in endometrial cancer patients: a cross-sectional study in South China. Curr Oncol 2023;30:3787-99. DOI PubMed
PMC
21. Tai J, Hsu CW, Chen WT, et al. Association of liver fibrosis with extrahepatic cancer in steatotic liver disease patients with PNPLA3
I148M GG genotype. Cancer Sci 2024;115:564-74. DOI PubMed PMC
22. Dolce A, Della Torre S. Sex, nutrition, and NAFLD: relevance of environmental pollution. Nutrients 2023;15:2335. DOI PubMed
PMC
23. Yang L, Tu PH, Zhang CX, et al. Influence of two anti-tumor drugs, pazopanib, and axitinib, on the development and thyroid-axis of
zebrafish (Danio rerio) embryos/larvae. Front Endocrinol 2023;14:1204678. DOI PubMed PMC
24. Wahlang B, Jin J, Beier JI, et al. Mechanisms of environmental contributions to fatty liver disease. Curr Environ Health Rep
2019;6:80-94. DOI PubMed PMC
25. Sen P, Qadri S, Luukkonen PK, et al. Exposure to environmental contaminants is associated with altered hepatic lipid metabolism in
non-alcoholic fatty liver disease. J Hepatol 2022;76:283-93. DOI
26. Rives C, Fougerat A, Ellero-Simatos S, et al. Oxidative stress in NAFLD: role of nutrients and food contaminants. Biomolecules
2020;10:1702. DOI PubMed PMC
27. Liu W, Li M, Guo H, et al. Single-cell transcriptome analysis of liver immune microenvironment changes induced by microplastics in
mice with non-alcoholic fatty liver. Sci Total Environ 2024;912:168308. DOI
28. Ye Z, Liu M, He P, et al. Various ambient air pollutants, residential green spaces, fibrosis 4 scores, genetic susceptibility, and risk of
severe liver disease. Ecotoxicol Environ Saf 2023;263:115246. DOI
29. Tovoli F, Stefanini B, Mandrioli D, et al. Exploring occupational toxicant exposures in patients with metabolic dysfunction-associated
steatotic liver disease: a prospective pilot study. Dig Liver Dis 2023;Online ahead of print:S1590-8658(23)01097-6. DOI
30. Wen Q, Liu T, Yu Y, et al. Self-reported primary cooking fuels use and risk of chronic digestive diseases: a prospective cohort study
of 0.5 million Chinese adults. Environ Health Perspect 2023;131:47002. DOI PubMed PMC
31. Cazzolla Gatti R, Di Paola A, Monaco A, Velichevskaya A, Amoroso N, Bellotti R. The spatial association between environmental
pollution and long-term cancer mortality in Italy. Sci Total Environ 2023;855:158439. DOI PubMed
32. Eom SY, Choi J, Bae S, et al. Health effects of environmental pollution in population living near industrial complex areas in Korea.
Environ Health Toxicol 2018;33:e2018004. DOI PubMed PMC
33. Korsh J, Shen A, Aliano K, Davenport T. Polycyclic aromatic hydrocarbons and breast cancer: a review of the literature. Breast Care
2015;10:316-8. DOI PubMed PMC
34. Park JH, Hong S, Kim OH, et al. Polypropylene microplastics promote metastatic features in human breast cancer. Sci Rep
2023;13:6252. DOI PubMed PMC
35. Sulaiman SA, Dorairaj V, Adrus MNH. Genetic polymorphisms and diversity in nonalcoholic fatty liver disease (NAFLD): a mini
review. Biomedicines 2022;11:106. DOI PubMed PMC
36. George ES, Sood S, Kiss N, et al. The evidence surrounding non-alcoholic fatty liver disease in individuals with cancer: a systematic
literature review. Curr Oncol 2022;30:48-74. DOI PubMed PMC
37. Ballestri S, Mantovani A, Di Girolamo M, Baldelli E, Capitelli M, Lonardo A. Liver fibrosis in nonalcoholic fatty liver disease
patients: noninvasive evaluation and correlation with cardiovascular disease and mortality. Metab Target Organ Damage 2023;3:1.
DOI